Repository logo
 

The delayed kinetics of Myddosome formation explains why amyloid-beta aggregates trigger Toll-like receptor 4 less efficiently than lipopolysaccharide.

Preprint

Repository DOI


Change log

Authors

Li, Bing 
Brelstaff, Jack 

Abstract

The Myddosome is a key innate immune signalling platform. It forms at the cell surface and contains MyD88 and IRAK proteins which ultimately coordinate the production of pro-inflammatory cytokines. Toll-like receptor 4 (TLR4) signals via the Myddosome when triggered by lipopolysaccharide (LPS) or amyloid-beta (Aβ) aggregates but the magnitude and time duration of the response are very different for reasons that are unclear. Here, we followed the formation of Myddosomes in live macrophages using local delivery of TLR4 agonist to the cell surface and visualisation with 3D rapid light sheet imaging. This was complemented by super-resolution imaging of Myddosomes in fixed macrophages to determine the size of the signalling complex at different times after triggering. Myddosomes formed more rapidly after LPS than in response to sonicated Aβ 1-42 fibrils (80 vs 372 s). The mean lifetimes of the Myddosomes were also shorter when triggered by LPS compared to sonicated Aβ fibrils (170 and 220 s), respectively. In both cases, a range of Myddosome of different sizes (50-500 nm) were formed. In particular, small round Myddosomes around 100 nm in size formed at early time points, then reduced in proportion over time. Collectively, our data suggest that compared to LPS the multivalency of Aβ fibrils leads to the formation of larger Myddosomes which form more slowly and, due to their size, take longer to disassemble. This explains why sonicated Aβ fibrils results in less efficient triggering of TLR4 signalling and may be a general property of protein aggregates.

Description

Peer reviewed: True


Acknowledgements: The electron microscopy work was performed using the facilities at CAIC (Cambridge Advanced Imaging Centre). This work was funded by the Alzheimer’s research UK, EPSRC (EP/W015005/1), BBSRC (BB/V000276/1), the Royal Society, and the UK Dementia Research Institute which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research UK.

Keywords

Myddosome, TLR4, amyloid beta, fluorescence imaging, immunology, inflammation, none, Toll-Like Receptor 4, Amyloid beta-Peptides, Lipopolysaccharides, Myeloid Differentiation Factor 88, Animals, Mice, Kinetics, Macrophages, Interleukin-1 Receptor-Associated Kinases, Signal Transduction

Journal Title

eLife

Conference Name

Journal ISSN

2050-084X

Volume Title

13

Publisher

eLife Sciences Publications, Ltd
Sponsorship
BBSRC (BB/V000276/1)
EPSRC (EP/W015005/1)